Background: Pulmonary embolism (PE) produces ventilation/perfusion mismatch that may be manifested in various variables of the volume-based capnogram (VBC). We hypothesized that a neural network (NN) system could detect changes in VBC variables that reflect the presence of a PE. Methods: A commercial VBC system was used to record multiple respiratory variables from consecutive expiratory breaths. Data from 12 subjects (n ‫؍‬ 6 PE؉ and n ‫؍‬ 6 PE؊) were used as input to a fully connected back-propagating NN for model development. The derived model was tested in a prospective, observational study at an urban teaching hospital. Volumetric capnograms were then collected on 53 test subjects: 30 subjects with PE confirmed by pulmonary angiography or diagnostic scintillation lung scan, and 23 subjects without PE based on pulmonary angiography. The derived NN model was applied to VBC data from the test population. Results: Seventeen VBC variables were used by the derived NN model to generate a numeric probability of PE. When the derived NN model was applied to VBC data from the 53 test subjects, PE was detected with a sensitivity of 100% (95% CI ‫؍‬ 89% to 100%) and a specificity of 48% (95% CI ‫؍‬ 27% to 69%). The likelihood ratio positive [LR(؉)] for the VBC-NN test was 1.82 and the LR (؊) was 0.1. Conclusion: This study demonstrates the feasibility of developing a rapid, noninvasive breath test for diagnosing PE using volumetric capnography and NN analysis.
T
he process of distinguishing patients with pulmonary embolism (PE) from patients without PE remains a notorious conundrum in modern medical practice. [1] [2] [3] [4] It is widely recognized that PE cannot be reliably excluded on the basis of clinical features alone. 2, [5] [6] [7] [8] [9] Therefore, clinicians are heavily dependent on imaging studies to screen for PE. 4, 8, 10 Standard imaging methods (eg, scintillation lung scan or CT) have many drawbacks as screening modalities for PE including the time, special expertise, and costs that are required to complete these examinations. These requirements are especially vexing in high-volume accident and emergency departments or medical clinics. The development of a reliable, rapid, and noninvasive screening tool for PE would improve the throughput of patients in hectic accident and emergency departments or medical clinics. 11 Computer-based neural networks (NN) may provide the analytical basis for an accurate, simple screening modality to exclude PE. NNs are an interconnected group of mathematical equations that can be arranged in a nonlinear fashion to derive relationships from input data to arrive at a known output. This "trained mathematical" paradigm can then be tested using additional naive input data. 12 Application of NNs to clinical medicine has been widespread, varying from identification of acute myocardial infarction to diagnosing appendicitis. 13 Patil et al 14 used historical, risk factor, physical examination, and laboratory data as model inputs to an NN and found the output of the NN to equal the diagnostic accuracy of experienced clinicians in recognizing PE.
PE produces ventilation/perfusion ratio (V /Q ) mismatches, which may be manifested by the expiratory volume-based capnogram (VBC). 15, 16 Volumetric capnography measures expiratory CO 2 tension as a function of expiratory volume. From previous publications, it could be expected that PE and the attendant increased alveolar dead space will attenuate several variables that define the VBC (end-tidal CO 2 , 17,18 mixed-expiratory CO 2 , 19 and slope and area of the capnogram plateau 20, 21 ). We therefore hypothesized that an NN could be trained to detect the alterations in the VBC produced by PE. The aim of this project was to combine the discriminative power of an NN with volumetric capnography to produce a rapid, noninvasive screening device for PE.
Materials and Methods

Design
We performed a prospective, observational study at an urban teaching hospital with 840 acute-care beds, and a 95,000-patient annual census in the emergency department. Prospective data collection began October 1997 and ended May 1998. The study was approved by the Carolinas Medical Center Institutional Review Board for clinical research.
NN Development
Heuristic Phase: The NN developed was a fully connected, back-propagating, nonadaptive system. The model was derived using commercial software (Neuralware Inc; Pittsburgh, PA) and incorporated into a macro to be executed out of an Excel (Microsoft; Seattle, WA) spreadsheet containing VBC data from each test subject. Data from 12 subjects (n ϭ 6 PEϩ [3 with high-probability lung scans, 3 with positive pulmonary angiography {PAG}] and n ϭ 6 age-matched healthy subjects) were used as input for model derivation. The NN generated an output ranging from 0 to 1.0, where 0 indicated no PE and 1.0 indicated presence of PE. Output values Ͼ 0.80 and Ͻ 0.20 were considered "positive" and "negative," respectively, for PE diagnosis. All values between 0.20 and 0.80 were considered "undecided."
Test Phase: The ability of the derived model to detect or exclude PE was examined during the 8-month prospective test phase, during which high-risk subjects were examined by the VBC-NN system and its output was compared with the reference standard for PE diagnosis. For each test subject, the median VBC-NN output of 11 consecutive breaths was used for diagnosis.
Test Phase Study Population
Inclusion Criteria: Subjects who underwent PAG or who had scintillation V /Q lung scans that were interpreted by a boardcertified radiologist as indeterminate, moderate, or high probability for PE were eligible for study entry. Lung scans were interpreted on the basis of criteria outlined in the Prospective Investigation of Pulmonary Embolism Diagnosis study. 18, 22 Clinical probabilities were not considered as part of study enrollment.
All subjects were enrolled by one of two study investigators who were on-call 24 h a day from October 1997 to May 1998. Extensive efforts were made to capture all subjects who met the inclusion criteria. For example, nuclear medicine and angiography technicians were offered a monetary stipend for contacting a study investigator about a potential study subject.
Exclusion Criteria: Patients were excluded for clinical evidence of circulatory shock, inability to tolerate breathing room air for 5 min, refusal or inability to give informed consent, refusal to stay for complete medical evaluation, cognitive impairment that prevented compliance with the testing procedure, or concurrent thrombolytic treatment or Ͼ 12 h of heparin therapy. Subjects were also excluded if they were entered on the basis of an indeterminate or moderate probability lung scan but did not undergo PAG.
Data Collection
After informed consent, a standardized clinical data form was completed by one of two study physicians at the time of capnograph measurements (Access8; Microsoft). Volumetric capnograms were obtained at bedside using a commercially available VBC machine (CO2SMO plus; Novametrix; Wallingford, CT), which is capable of simultaneously recording time-based capnograms, mixed-expiratory CO 2 content, flow, and breath volume data. The VBC machine was connected via a serial port to a portable computer (Monorail), in which data were continuously recorded with proprietary software (Cosmoplus! for Windows, Novametrix). Both machines were mounted on a compact rolling stand. The capnograph was calibrated to a reference cell before each measurement. Breaths were obtained with the patient breathing room air in an approximately 45°semi-Fowler's position. Nose-clips were placed and the subjects were asked to breathe into a duckbill-shaped mouthpiece that was attached via airtight seal in series to a CO 2 flow sensor and adapter. Because the breath collection technique could distract the subject and potentially alter the respiratory pattern, each subject performed a trial run of breath collection. The examiner observed the sigmoidal VBC curves in real time on the computer screen as the subject breathed to confirm that consistent breath patterns were being recorded. Once the subject was accustomed to the equipment, consecutive expiratory breaths were recorded for approximately 2 min, and data were downloaded. Pulse oximetry was measured during VBC data collection. On-line breath data (capnograms, CO 2 data, flow and volume data) were archived and analyzed by the Cosmoplus program to generate 28 variables, which were exported to Excel (97 SR-1; Microsoft) for statistical and NN analysis. A complete technical description of the variable calculations is available from the Novametrix Medical Systems Corporation.
To examine the system for possible intra-and interobserver variability, volumetric capnograms were obtained in six volunteers with no symptoms of PE (three subjects who were smokers with history of recurrent bronchitis and three who had no lung disease). To test for intraobserver variability, three observers studied the six subjects on two occasions within an 8-h period. Two of the three observers were experienced with the data collection process, and one naive observer (no. 3) was given a 10-min training session and one practice run before data collection. The three observers collected breaths independently in random order and out of the view of the other observers.
Reference Standard for Diagnosing or Excluding PE
Lung scans were interpreted by one of three nuclear medicine radiologists who were blinded to clinical and study information.
Standard radioisotope imaging techniques were used as previously described. 18 Selective PAG was performed for patients with nondiagnostic lung scans; initial positioning of the pulmonary artery catheter was based on findings from the lung scan. If the first lung did not demonstrate any evidence for PE, the second lung was imaged in all cases. Precise volume and rate of contrast injection was tailored to produce adequate images on real-time cineangiography; views were obtained in anterior-posterior, lateral, and oblique projections. Final readings of PAG were based on review by one of three interventional radiologists who were blinded to clinical and study data. PE was confirmed in subjects with (1) high-probability lung scans, consisting of two or more segmental wedge-shaped, apex-central, perfusion defects that demonstrated homogenous 99m Tc aerosol ventilation; or (2) PAG that demonstrated arterial cutoff or an intraluminal filling defect. PE was excluded in subjects with a PAG that did not reveal any evidence of PE.
Statistical Analysis
Sample Size: The primary study objective was to develop a system with a very high test sensitivity. It was decided a priori that the lower limit of the 95% confidence interval (CI) for sensitivity should be approximately 90%; thus, 30 subjects with confirmed PE were required for the testing phase of this study.
Comparison of Data:
Comparison of clinical and VBC data was made between PEϩ and PE-excluded groups using the 95% CI for differences in proportions or means (Confidence Interval Analysis, CIA, version 1). Mean (Ϯ SD) is shown for continuous variables. The plot of the posttest probability of PE after the VBC-NN system was compared with the plot of the posttest probability of PE after the V /Q scan with a Wilcoxon signed rank sum test.
Results
A total of 56 subjects were enrolled in the testing phase of the study (ie, after the initial 12 used to train the NN). Three subjects were excluded from analysis (see below). Thirty-five patients underwent PAG, which was positive for PE in 12 (34%) and negative in 23 (66%). Eighteen subjects were diagnosed with PE on the basis of a high-probability scintillation lung scan; the mean number of complete, unmatched segmental perfusion defects was 6.7 Ϯ 4.4 segments with a range of 2 to 16 segments. All of the PE-excluded subjects reported in the testing phase of the NN (n ϭ 23) underwent PAG, which was negative for PE.
Clinical Features of Test Population
Clinical data are summarized in Tables 1-3 . Demographic data (mean age and sex distribution) of the two groups (PE-excluded and PEϩ) were not different (Table 1) . No individual risk factor was significantly different between the two groups ( Table  2) . Among signs and symptoms, dyspnea was significantly more common in the PE-confirmed group and vice versa for chest pain (Table 3) . No other risk factor or symptom was significantly different in the PE-confirmed vs the PE-excluded group (Table 3) .
Application of the NN
The VBC system outputs 28 respiratory variables, of which 17 were suitable for NN model inputs. Eleven variables were excluded. Two nonaveraged tidal volume (Vt) measurements were redundant with the averaged Vt (ie, the software determines the maximal inspiratory and expiratory Vt measured during the preceding three breaths; these calculations are not averages, therefore, only the average Vt was included as a model input). Nine variables were excluded because they were not applicable to spontaneous breathing (ie, applicable only with mechanical ventilation). Descriptive statistical data of the 17 selected variables are presented in Table 4 . Of the 17 inputs, six VBC variables were significantly weighted in the tested model: end-tidal CO 2 , peak expiratory flow, the slope of the phase III plateau (see reference 15 for explanation), total minute ventilation (V e), alveolar V e, and inspiratory time (Ti). Moreover, the 95% CIs for the difference in means of these six variables were also significant between groups.
Diagnostic Performance of the NN
An output of 0 to 0.20 was considered negative for PE; 0.21 to 0.79 was considered indeterminate for PE; and 0.80 to 1.0 was positive for PE. For all of the subjects in the PE-confirmed group (n ϭ 30), the NN derived an output ranging from 0.97 to 1.00. Thus, the NN demonstrated a sensi- tivity of 100% (95% CI ϭ 89 to 100%). Among the PE-excluded subjects (n ϭ 23), the NN determined one subject to be indeterminate and derived an output of 0.54. There were 11 falsepositive subjects with the NN-derived output ranging from 0.98 to 1.00. If the indeterminate reading is considered positive, the test specificity is 48% (95% CI ϭ 27 to 69%). Table 5 presents diagnostic indexes to compare the results of the NN with the results of the criteria standard for PE (diagnostic positive lung scan or result of PAG). Using the midpoint of the 95% CI for sensitivity for calculation purposes, a likelihood ratio positive [LR(ϩ)] of 1.82, and an LR(Ϫ) of 0.10 are obtained. Figure 1 compares the performance of the VBC-NN system with the V /Q scan by plotting the posttest probability for PE as a function of disease prevalence. 23 For the V /Q scan, a reading of normal or near normal was considered as categorically negative for PE (98% sensitive and 10% specific). 22 Thus an LR(Ϫ) of 0.20 was used to generate the diagnostic performance curve for the V /Q scan in Figure 1 . The figure shows that the diagnostic performance of the VBC-NN is significantly higher than the normal or near normal V /Q scan across a wide range of PE prevalence (p Ͻ 0.01, Wilcoxon signed rank sum test).
Excluded Subjects
Three of the initial 56 subjects were excluded from the study for the following reasons: (1) A subject with *Results are given as number (%). DVT ϭ deep vein thrombosis. There were no significant differences for any reported proportion between subjects with PE-confirmed vs PE-excluded (95% CI for difference crosses zero for all proportions). †Cardiac disease includes congestive heart failure and coronary artery disease. ‡Lung disease includes COPD, asthma, fibrosis, and sarcoidosis. an indeterminate scan and a lower extremity deep venous thrombosis did not receive a PAG. The NN classified the subject as negative for PE. (2) A subject under the influence of cocaine had a moderate probability lung scan with several subsegmental perfusion defects and a lower extremity venous Doppler ultrasound that was negative for deep venous thrombosis, and refused PAG. The NN classified the subject as negative for PE. (3) A subject had a positive PAG but a mixed-expiratory and end-tidal CO 2 that was too low to be accurately detected by VBC system, and therefore the output could not be analyzed by the NN program.
Intra-and Interobserver Variability for VBC Data
Three observers collected breaths on two separate occasions from six subjects. The data presented in Table 6 were reduced to the six variables that carried statistical significance and significant weight in the NN model. For each patient, data from seven consecutive steady-state breaths were averaged, and these means were averaged for the six patients to yield the summary means for two observations made by each observer (Table 6) . Additionally, Table 6 shows the percentage change in means from the first to the second measurement for each observer, the maximal percentage differences between observers, and the corresponding Pearson's correlation coefficient. For all six measurements that were significantly weighted by the NN, the variability in means was Յ 10%, and fell within a range Ϯ one standard deviation, both within and between observers. The lowest Pearson's correlation coefficient between observers with the maximal differences for each variable was 0.79. These data demonstrate excellent agreement between observers. 24 The NN classified the same five of six subjects as negative for PE for all observers on both measurements.
Discussion
An accurate, rapid, and noninvasive screening test for pulmonary embolism would greatly assist clinicians who practice in emergency departments or outpatient medical clinics. 1, 10, 25 The clinical presentation of PE and its distinction from other diseases is problematic for even the most skilled clinicians. 9, 26 This preliminary study demonstrates the feasibility of combining NN analysis and VBC as a screening tool for PE. This tool integrates the technology of NN and VBC to detect objective physiologic changes produced by PE in a group of subjects who were not easily separated from subjects without PE using standard clinical data. NNs have been used to detect PE previously. However, those studies applied neural analysis to the interpretation of data either from scintillation lung scan or from standard clinical information. 14, 27 Because the clinical presentation of PE can be vague, and the findings minimal, recognition of clinical manifestations of PE may be highly dependent on the skill and experience of the clinician. 2,3,5,9,28 -30 Thus, training an NN model with subjective, clinician-derived data could hinder its test performance when used by other clinicians. To overcome this potential limitation in the clinical utility of the NN, we used objective respiratory variables derived from volumetric capnography to train the NN. We hypothesized that the NN would gain discriminative power very rapidly by analyzing the output of a volumetric capnograph. Volumetric capnography has only recently become available for commercial use. However, the scientific basis for the use of volumetric capnography to screen for PE has been recognized for Ն 30 years. 19, 31, 32 PE causes several physiologic alterations, which may be manifested in the respiratory variables measured by the volumetric capnograph. One such physiologic alteration with PE is the development of alveolar dead space.
Pulmonary dead space is divided into two components, airway dead space and alveolar dead space (collectively termed physiologic dead space). Airway dead space comprises the conducting portions of the respiratory tract, extending from the lips or nares to the fresh air-alveolar interface at the terminal end of the bronchial tree. Airway dead space increases with chronic asthma and emphysema. Unlike airway dead space, alveolar dead space increases when alveoli are ventilated but the alveolar gas does not equilibrate with pulmonary capillary blood. PE causes a decrease in blood flow to alveoli, which are usually well ventilated in the acute phase of embolism. 33 Gas that passes through the alveoli that are distal to a PE contains a very low tension of CO 2 , which mixes with and dilutes the CO 2 content of gas from alveoli that are well perfused. Consequently, as PE increases the alveolar dead space, it also decreases the CO 2 content of expiratory breath and flattens the plateau of the CO 2 -volume capnogram. 20 Additionally, V e increases. 34, 35 The increased rate of ventilation may reflect a compensation for the increased percentage of each breath that is wasted on underperfused alveoli. PE, on the other hand, minimally affects, or decreases, airway dead space secondary to hypocarbic bronchoconstriction. 36, 37 Figure 1. Diagnostic performance of the VBC-NN system compared with the V /Q scan at different prevalences of PE. A negative V /Q scan was considered normal or near-normal. Thus, the present work draws from previous studies that used the dead space to screen for PE. The previous studies estimated the dead space by either time-based capnography, 18, 38 by a capnograph-pneumotachograph-personal computer arrangement, 16, 39 or by Douglas bag-mass spectrometry. 19 The dead space calculations also required arterial blood gas analysis to be performed at the time of respiratory measurements. The system described in the present report does not require the collection of arterial blood and uses portable, lightweight, commercially available equipment for breath collection and analysis.
The clinical and the demographic data presented in Tables 1-3 show that subjects in the PEϩ and PEϪ groups were not distinguishable on the basis of these data. The clinical data showed only two differences of 29 total that were found to be statistically significant. First, subjects with PE were more likely to complain of dyspnea (95% CI for 33% difference was 10 to 54%), and, second, subjects with PE were less likely to complain of chest pain (95% CI for 28% difference was Ϫ55 to Ϫ3%). As evidenced by the tables, subjects with PE would have been tremendously difficult to discern on the basis of clinical or demographic data alone. We attempted multiple sorting strategies of the raw data summarized in Tables 1-3 , in an effort to find a combination of clinical features that would rule out PE in all 30 subjects (eg, absence of dyspnea ϩ pulse oximetry of 100% ϩ no risk factors for PE). We could identify no combination of clinical features that excluded PE with 100% sensitivity and Ͼ 0% specificity.
However, analysis of VBC data revealed six variables that were significantly different between groups. As was expected, these variables included indexes of CO 2 elimination (end-tidal CO 2 and the slope of phase III) as well as ventilatory indexes (peak expiratory flow, spontaneous V e, alveolar V e, and Ti, Table 4 ). Of note, VBC data were easily obtained by having the patient breathe with nostrils shut into a mouthpiece for 2 minutes. We postulate that these data are less susceptible to the effect of interobserver variability, as opposed to clinical recognition of clinical symptoms of PE that may be dependent on the experience level and the time spent by the clinician. Table 4 also presents objective evidence that the NN was provided with adequate "substrate data" to be able to distinguish between subjects with and without PE. These data thus help to dispel the notion that the NN functioned as a "black box" in the present report.
The novel system has several characteristics that would promulgate its use at a busy emergency department or medical clinic: it is rapid, noninvasive, portable, and remarkably easy to use. A semiskilled technician can be trained within minutes to use the system. Importantly, the system detected PE in all 30 PEϩ subjects, indicating the sensitivity and LR(Ϫ) will probably remain high if this system is retested in other settings. Moreover, many of the PEϩ subjects in this study were difficult cases. For example, three subjects had low-probability lung scan readings, and four had indeterminate or intermediate-probability lung scans with subsequent PAGs positive for PE. One subject with a lowprobability lung scan reading had a small subsegmental PE on angiography. The NN accurately diagnosed PE in each of these subjects. A bedside breath test for PE that possesses nearly 100% sensitivity could reduce dependence on expensive and time-consuming imaging examinations. Moreover, this prototype can be remodeled to develop a VBC-NN system to be used as a surveillance instrument for monitoring patients at risk for PE in a manner analogous to how the 12-lead ECG is used to follow up patients at risk for myocardial ischemia.
The major limitation of this system was its low specificity (lower limit of 95% CI ϭ 27%). In this study, the VBC-NN system was tested on a selected population with a very high prevalence of PE (Ͼ 50%). However, Figure 1 indicates that if this device were tested in a population with a different prevalence of disease, then the posttest probability of PE would compare favorably with the use of a normal or nearnormal V /Q scan as a screening device for PE. We also believe that the low specificity is mitigated somewhat in view of the demographic and clinical data of the PE-excluded group: the study group represented an extreme diagnostic challenge. All subjects in the PEexcluded group had nondiagnostic lung scans (including eight indeterminate or moderate-probability results), and all subjects required a PAG because of diagnostic uncertainty. In 15 of 23 cases, a boardcertified pulmonologist was consulted to assist in clinical decision making. The test population therefore represented a difficult diagnostic challenge to test the NN model. A question does arise as to whether the VBC-NN system can distinguish the breath data from a patient with PE compared with breath data from a patient who is hyperventilating. From the mean respiratory rate, and review of final diagnoses, it would appear that very few of the 20 subjects with PEexcluded were "hyperventilating," so the present data cannot answer that question. It remains possible that hyperventilation could cause a false-positive output from the VBC-NN. An ongoing multicenter study will permit a better determination of the specificity of the VBC-NN system in ambulatory emergency department patients with suspected PE, where hyperventilation is more likely to be named as a final diagnosis.
Summary
This was a preliminary study with a relatively small population that tested the feasibility of neural analysis using volumetric capnography. As a screening tool for PE, this model demonstrated 100% sensitivity in 30 subjects with confirmed PE and 48% specificity in 23 subjects with PAG that gave negative results for PE. This study therefore documents the potential for the development of a simple breath test for PE that could assist clinicians in busy outpatient facilities.
